Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1Phase 1 1

Status

Completed 22Not yet recruiting 3Unknown 2Terminated 2Recruiting 2Enrolling by invitation 1

Sponsor Class

OTHER 2

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Stomach Neoplasms 1Gastroesophageal Reflux 1Gastritis 1Esophagitis 1Barrett Esophagus 1

Interventions

Cisplatin 509Cyclophosphamide 360Carboplatin 352Radiotherapy 350Capecitabine 329Paclitaxel 325Oxaliplatin 324Gemcitabine 319Docetaxel 311Fluorouracil 283Drug Therapy 243apatinib 242Bevacizumab 229camrelizumab 214Etoposide 200Irinotecan 176Doxorubicin 175Leucovorin 161Dexamethasone 160sintilimab 142pembrolizumab 138anlotinib 136Pemetrexed 136Cytarabine 136toripalimab 129Neoadjuvant Therapy 122S 1 (combination) 120Vincristine 119Rituximab 117Radiosurgery 117

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Unknown × Interventional × Esomeprazole × Clear all
NCT05100446 2021-10-29

Comparison Between High-dose Amoxicillin Dual Therapy and Pylera Quadruple Therapy in the Treatment of Helicobacter Pylori Infection

Unidade Local de Saúde do Alto Ave, EPE

Phase EARLY_PHASE1 Unknown
100 enrolled
Gastrointestinal

Gastritis, Stomach Neoplasms

NCT00216788 2010-03-16

The Effect of Nexium on Transmucosal Esophageal Leak

Main Line Health

Phase 1 Unknown
35 enrolled
Gastrointestinal

Barrett Esophagus, Esophagitis, Gastroesophageal Reflux

Data powered by HemOnc (CC BY 4.0) Colophon âš¡